Publication date: Dec 10, 2024
To analyse the effects of tracheostomy timing on COVID-19 outcomes by comparing mortality rates at different time points (7, 10 and 14 days). Systematic review and meta-analysis. PubMed, Embase, Cochrane Library, Web of Science and Scopus were searched from 31 August 2023 to 6 September 2023. The primary outcome was short-term mortality, defined as intensive care unit (ICU) mortality, hospital mortality and 28-day or 30-day mortality. The secondary outcomes included mechanical ventilation duration, ICU and hospital days. Among 3465 patients from 12 studies, the 10-day subgroup analysis revealed higher mortality for earlier tracheostomy than for later tracheostomy (49. 7% vs 32. 6%, OR 1. 91, 95% CI 1. 37-2. 65). No significant differences were observed at 7- and 14-day marks. Earlier tracheostomy was associated with shorter mechanical ventilation (mean difference=-7. 35 days, 95% CI -11. 63 to -0. 38) and ICU stays (mean difference=-11. 24 days, 95% CI -18. 50 to -3. 97) compared with later tracheostomy. Regarding hospital stay, the later tracheostomy group exhibited a trend towards longer-term inpatients, with no significant difference. No significant difference in short-term mortality was observed between patients undergoing tracheostomy at 7 and 14 days; however, at 10 days, later tracheostomy resulted in a lower mortality rate. Accordingly, subtle timing differences may impact short-term results in COVID-19 patients. Considering that the later tracheostomy group had longer mechanical ventilation and ICU stays, additional research is required to determine an optimal timing that reduces mortality cost-effectively.
Open Access PDF
Semantics
Type | Source | Name |
---|---|---|
disease | MESH | COVID-19 |
drug | DRUGBANK | Dihydrotachysterol |
drug | DRUGBANK | Tocilizumab |
disease | MESH | infections |
disease | MESH | complications |
disease | MESH | laryngeal stenosis |
disease | MESH | fistulas |
disease | IDO | process |
drug | DRUGBANK | Methionine |
disease | MESH | respiratory failure |
disease | IDO | country |
disease | IDO | quality |